These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29467370)

  • 21. Short repetition time diffusion-weighted imaging improves visualization of prostate cancer.
    Higaki A; Tamada T; Kido A; Takeuchi M; Ono K; Miyaji Y; Yoshida K; Sanai H; Moriya K; Yamamoto A
    Jpn J Radiol; 2024 May; 42(5):487-499. PubMed ID: 38123889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed?
    de Perrot T; Scheffler M; Boto J; Delattre BM; Combescure C; Pusztaszeri M; Tille JC; Iselin C; Vallée JP
    J Magn Reson Imaging; 2016 Sep; 44(3):601-9. PubMed ID: 26914964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.
    Lim HK; Kim JK; Kim KA; Cho KS
    Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image Quality Assessment of 2D
    Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
    Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer.
    Delli Pizzi A; Caposiena D; Mastrodicasa D; Trebeschi S; Lambregts D; Rosa C; Cianci R; Seccia B; Sessa B; Di Flamminio FM; Chiacchiaretta P; Caravatta L; Cinalli S; Di Sebastiano P; Caulo M; Genovesi D; Beets-Tan R; Basilico R
    Abdom Radiol (NY); 2019 Nov; 44(11):3595-3605. PubMed ID: 31444557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis.
    Wetter A; Nensa F; Lipponer C; Guberina N; Olbricht T; Schenck M; Schlosser TW; Gratz M; Lauenstein TC
    Acta Radiol; 2015 Aug; 56(8):1009-15. PubMed ID: 25168023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion-weighted magnetic resonance imaging without bowel preparation for detection of ulcerative colitis.
    Yu LL; Yang HS; Zhang BT; Lv ZW; Wang FR; Zhang CY; Chen WB; Zhang HM
    World J Gastroenterol; 2015 Sep; 21(33):9785-92. PubMed ID: 26361426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
    Luzurier A; Jouve De Guibert PH; Allera A; Feldman SF; Conort P; Simon JM; Mozer P; Compérat E; Boudghene F; Servois V; Lucidarme O; Granger B; Renard-Penna R
    J Magn Reson Imaging; 2018 Oct; 48(4):1012-1023. PubMed ID: 29517822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
    Liu X; Zhou L; Peng W; Wang C; Wang H
    Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imaging.
    Kwak JT; Xu S; Wood BJ; Turkbey B; Choyke PL; Pinto PA; Wang S; Summers RM
    Med Phys; 2015 May; 42(5):2368-78. PubMed ID: 25979032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative Apparent Diffusion Coefficient Derived From Diffusion-Weighted Imaging Has the Potential to Avoid Unnecessary MRI-Guided Biopsies of mpMRI-Detected PI-RADS 4 and 5 Lesions.
    Polanec SH; Helbich TH; Bickel H; Wengert GJ; Pinker K; Spick C; Clauser P; Susani M; Shariat S; Baltzer PAT
    Invest Radiol; 2018 Dec; 53(12):736-741. PubMed ID: 29985792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
    Park SY; Kim CK; Park BK; Kwon GY
    AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
    Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
    Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
    Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
    J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Segmented diffusion-weighted imaging of the prostate: Application to transperineal in-bore 3T MR image-guided targeted biopsy.
    Fedorov A; Tuncali K; Panych LP; Fairhurst J; Hassanzadeh E; Seethamraju RT; Tempany CM; Maier SE
    Magn Reson Imaging; 2016 Oct; 34(8):1146-54. PubMed ID: 27240900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
    Kim CK; Park BK; Kim B
    AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
    Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
    Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
    Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
    Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
    Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
    Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.
    Van Nieuwenhove S; Saussez TP; Thiry S; Trefois P; Annet L; Michoux N; Lecouvet F; Tombal B
    BJU Int; 2019 Mar; 123(3):411-420. PubMed ID: 30240059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.